Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression
about
FBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cellsHow many diseases are colorectal cancer?Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximabCancer subclonal genetic architecture as a key to personalized medicine.EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationEGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform.
P2860
Q33655198-6D41D8CC-70F9-4AC6-AD5B-BF8BA994B670Q36238965-F34BCB37-5474-45D1-89BD-A510AF5BA791Q37285565-09C134DC-A7BA-424A-8721-548E55CB52C3Q37448116-C0A73A94-7638-4D52-BD45-2C4A01711820Q41219232-0ECB01B3-291F-40D6-9C38-40FCF6A7C673Q41879186-6D455136-8378-4700-9306-DA23D40E1F68Q46117259-31C051E1-A4D1-457D-8623-7BCB445B9270
P2860
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@ast
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@en
type
label
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@ast
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@en
prefLabel
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@ast
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@en
P2093
P2860
P356
P1433
P1476
Oncogenic KRAS impairs EGFR an ...... suppression of EGFR expression
@en
P2093
Andreas H Scheel
Iris Nagelmeier
Jan G J van de Winkel
Jeroen J Lammerts van Bueren
Katja Klausz
Marije B Overdijk
Martin Schlaeth
Matthias Peipp
Michael Dechant
Stefan Lohse
P2860
P304
P356
10.1593/NEO.111636
P577
2012-03-01T00:00:00Z